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Abstract Transgenesis can be achieved in mice by retroviral
transduction of male germ line stem cells (GSCs). However, the
transduction e⁄ciency by a Moloney murine leukemia virus
(MMLV)-based vector is low, probably due to the characteristi-
cally slow cell cycle of stem cells. Since lentiviral vectors can
transduce non-dividing cells, they have the potential to e⁄-
ciently transduce GSCs. Here we report that male GSCs of
mice can be transduced in vitro by a lentiviral vector and gen-
erate complete spermatogenesis when transplanted into infertile
host testes. Transduction e⁄ciencies were comparable to those
for MMLV transduction using similar experimental conditions.
The results suggest that both lentiviral and MMLV vectors
could be e¡ective in transducing GSCs of other species. In ad-
dition, these and previous studies suggest that transduction of
immature donor stem cells transplanted into immature recipient
testes will provide the most e⁄cient system for male germ line
modi¢cation. * 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Spermatogonial stem cells, the germ line stem cells (GSCs)
of the male in postnatal mammals, are the foundation of
spermatogenesis [1,2]. The GSCs self-renew throughout life
and produce committed progenitors that subsequently enter
meiosis and form spermatozoa. This dual function of GSCs
confers a lifelong reproductive potential to a male after pu-
berty. In contrast, all female germ cells enter meiosis and lose
their self-renewing potential prior to birth, resulting in the
absence of GSCs in postnatal females. Thus, male GSCs are
the only postnatal mammalian cell population that can self-
renew, maintain the dependent tissue, and contribute genes to
the next generation. Development of the spermatogonial
transplantation technique allowed any testis cell population
to be analyzed for the presence of this stem cell [3,4]. In
this technique, testis cells obtained from one male are trans-
ferred to the testes of another infertile male, and the GSCs
contained in the donor cell population colonize the seminif-
erous tubules of the recipient. Donor-derived spermatogenesis
is established in the testes of the recipient, which subsequently
produces o¡spring carrying the donor haplotype [3,4]. Thus
this technique has provided unique opportunities to manipu-
late the genome of o¡spring through male GSCs.
The oncoretrovirus, Moloney murine leukemia virus
(MMLV), has been one of the most frequently used vectors
to deliver a foreign gene into target cells due to its intrinsic
ability to integrate recombinant proviral DNA into the ge-
nome of a host cell [5,6]. We have previously demonstrated
that gene delivery into the genome of male GSCs is feasible in
mice using mouse-speci¢c ecotropic MMLV vectors [7,8]. Fol-
lowing in vitro retroviral transduction of donor GSCs, trans-
plantation of these cells into recipient seminiferous tubules
resulted in generation of donor-derived spermatogenesis ex-
pressing a marker transgene [7]. The recipients subsequently
produced transgenic o¡spring at a frequency (4.5%) compa-
rable to that observed in conventional transgenic strategies
using eggs and embryos [8]. The viral marker gene was ex-
pressed without silencing for at least three generations [8].
While these studies clearly indicate that MMLV-based vectors
are valuable for transgenesis through the male germ line, they
have a signi¢cant limitation for gene delivery to GSCs. Be-
cause the proviral DNA cannot translocate through the nu-
clear membrane, e⁄cient transduction by MMLV vectors re-
quires active host cell division, which is accompanied by
nuclear membrane breakdown [5,9]. Since GSCs divide slowly
[1], this requirement is a signi¢cant limiting factor in the ge-
netic modi¢cation of the male germ line using MMLV vec-
tors.
Lentiviruses are a subclass of retroviruses which have been
developed as vectors in order to deliver target genes to the
genome of non-dividing cells [5]. Lentiviral vectors, including
those based on the human immunode¢ciency virus, contain a
matrix protein with a nuclear localization sequence that en-
ables the viral pre-integration complex to be actively trans-
ported into the nucleus of a host cell [10]. Therefore, lentiviral
vectors can transduce non-dividing cells. In addition, the en-
velope protein of lentiviral vectors is commonly replaced with
the G glycoprotein of vesicular stomatitis virus (VSV-G),
which uses an abundant membrane phospholipid as a receptor
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and permits entry of these vectors into a wide range of cell
types from a variety of species [11]. Therefore, the lentiviral
vector could be an e⁄cient vehicle to deliver foreign genes
into male GSCs of many species.
In the present study, we used two types of lentiviral vectors,
which encoded the Escherichia coli lacZ reporter gene driven
by either a mammalian elongation factor (EF)-1K promoter or
a viral enhancer/promoter derived from cytomegalovirus, to
examine the transduction e⁄ciency of male GSCs in mice.
2. Materials and methods
2.1. Animals
Donor cells were obtained from adult and pup mouse testes. Adult
testis cells were collected from C57BL/6 (B6) males made cryptorchid
at 6^8 weeks of age, by securing the testes inside the abdominal cavity
to allow elimination of di¡erentiated germ cells [12]. Cells were col-
lected 2^3 months after surgery. This procedure results in a 20^25-fold
enrichment of stem cells [12,13]. Pup testis cells were collected from
B6U129/SvCP (B6/129) F1 hybrid mice at 5^8 days of age. Adult B6/
129 males were used as recipients; they were pretreated with 50 mg/kg
body weight of busulfan at 4^6 weeks of age to destroy endogenous
spermatogenesis, and used 4 weeks or more after treatment. All ani-
mal experimentation procedures were approved by the Institutional
Animal Care and Use Committee of the University of Pennsylvania.
2.2. Virus production
Viral vectors were produced as described [14]. HEK 293T cells were
plated on poly-D-lysine-coated 10-cm plates. One day later, cells were
transfected with 5 Wg of pMD.G (encoding the VSV-G envelope gly-
coprotein) [15], 15 Wg of pCMVvR8.2 (encoding viral structural, en-
zyme, and accessory genes) [15], and 20 Wg of the transfer plasmid,
either HIV-CMV-LacZ [15] or SIN-EF-nLacZ [16], using the CalPhos
transfection kit (Clontech). The cells were rinsed 12^16 h later, and
the medium was changed to the germ cell culture medium (Dulbecco’s
modi¢ed Eagle’s medium containing 10% fetal bovine serum, 6 mM
lactate, 0.5 mM pyruvate, 6 mM L-glutamine, 0.1 mM L-mercapto-
ethanol, 30 Wg/ml penicillin, and 50 Wg/ml streptomycin) [7]. Viral
supernatants were collected V48 h post-transfection, and centrifuged
at 200Ug for 5 min at 4‡C and passed through a 0.45-Wm ¢lter to
remove any contaminating virus producer cells. Unconcentrated vec-
tor stocks were used for transduction and titering immediately after
collection. Titering was performed on canine Cf2TH cells in the
presence of 8 Wg/ml polybrene (Sigma) using serial dilutions of viral
supernatants, and titers were determined by reacting the cells with
5-bromo-4-chloro-3-indolyl-L-D-galactopyranoside (X-gal) 48 h after
transduction [15,16]. The titer was V105 transduction U/ml for both
vectors (Table 1), which was similar to that of MMLV-based vectors
reported in previous studies [7,8].
2.3. In vitro manipulation of male GSCs by lentiviral vectors and
transplantation
In vitro culture and infection procedures were based on our pre-
vious studies with slight modi¢cations [7,8]. Testis cells were prepared
using a two-step digestion of donor testes, and 2U106 cells were
placed in a 9.6-cm2 tissue culture well [7]. Mitomycin C-treated SIM
mouse embryo-derived thioguanine- and ouabain-resistant (STO) ¢-
broblast cell line served as feeder cells (5U105 cells/well) [7]. Four
wells for each type of vector were prepared per experiment. The fol-
lowing day, donor testis cells were treated twice with freshly prepared
lentiviral supernatant (1 ml with 4 Wg/ml polybrene); ¢rst for 6^8 h
followed by a second treatment for 12 h. On the second day, cells
were washed with 3 ml of Dulbecco’s phosphate-bu¡ered saline three
times, harvested by trypsinization, resuspended in the germ cell cul-
ture medium, and transplanted into seminiferous tubules of recipient
testes [7,17]. Each recipient testis received approximately 10 Wl of cell
suspension. Recipient testes were stained with X-gal to detect donor-
derived spermatogenesis expressing the viral lacZ marker gene
2^3 months or 6 months following transplantation [17]. Recipient
seminiferous tubules were para⁄n-sectioned and counter-stained
with eosin to examine the morphology of donor-derived spermato-
genesis.
3. Results and discussion
We used lentiviral vectors with two di¡erent promoters,
each carrying the lacZ marker gene, to transduce male
GSCs. One vector (CMV-lacZ) contained an internal en-
hancer/promoter of cytomegalovirus (CMV) [15], and the oth-
er (EF-nlacZ) contained an internal promoter from EF-1K
and a nuclear translocation sequence [16]. Adult and pup
donor testis cells were transduced in vitro using each vector,
and transplanted into recipient testes to evaluate viral trans-
duction of GSCs. The transplantation assay is necessary be-
cause, based on current knowledge, GSCs can be identi¢ed
only by their ability to generate complete spermatogenesis.
Following transplantation of donor cells transduced by the
CMV-lacZ vector, no colonies of spermatogenesis expressing
Table 1
Colonization of recipient testes by male GSCs transduced by a lentiviral vector in vitro
Donor age Experiment
number
Viral titera
(U/ml)
Number of cells/testis
(U105)b
Number of testes
analyzedc
Number of testes
colonizedc
Number of
colonies observed
Testis cell
TEd
Adult 1 1.3U105 6.7 8 2 5 0.9
2 6.7U103 6.3 11 (4) 4 (0) 10 1.4
3 2.4U105 6.7 9 (2) 2 (0) 4 0.7
1^3e;f 1.3R 0.7U105e 6.6 R 0.1e 28 (6)f 8 (0)f 19f 1.0
Pup 4 3.5U105 5.3 6 6 15 4.7
5 4.6U103 6.7 8 (1) 8 (1) 11 2.1
6 4.8U104 5.7 9 (4) 9 (4) 36 7.0
4^6e;f 1.3R 1.1U105e 5.9 R 0.4e 23 (5)f 23 (5)f 62f 4.6
The lentiviral vector contained a reporter gene, EF-nlacZ. No donor cell colonization was observed in recipients of CMV-lacZ-transduced cells
using the same experimental conditions (44 testes analyzed; data not shown).
aThe viral titer was determined using canine Cf2TH cells and expressed as a mean of two titrations per experiment.
bNumber of cells/testis was calculated based on the number of testis cells originally placed in culture (8U106 cells in all experiments, except in
experiment 2, in which 7.6U106 cells were used). Cultured cells were harvested after 2 days and suspended in 120 Wl (experiments 1^3 and 5),
or 150 and 140 Wl (experiments 4 and 6), respectively. Approximately 10 Wl of each cell preparation was injected into a recipient testis. Thus, in
experiment 1, 6.7U105 cultured testis cells (8U106 cells U10 Wl/120 Wl) were injected per recipient testis.
cValues in parentheses indicate the number of recipient testes analyzed 6 months following transplantation. Other recipient testes were analyzed
2 or 3 months following transplantation. Thus, in experiment 2, four out of 11 recipient testes were analyzed at 6 months and no colonies
were found in these four testes.
dTestis cell TE represents the number of colonies generated from 106 testis cells originally placed in culture.
eMeanRS.E.M. Average of three experiments.
fTotal of three experiments.
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the lacZ marker gene were established in a total of 44 recip-
ient testes analyzed from three experiments with both donor
ages. Either this vector did not transduce GSCs or expression
of the reporter gene was suppressed in GSCs and di¡erenti-
ated germ cells arising from transduced stem cells. Suppres-
sion of reporter gene expression appears a more likely cause
because expression of the marker gene was seen in transduced
testis cells in vitro (not shown), and the CMV-lacZ vector
used in this study also transduced neural cells but its expres-
sion was silenced (D.J. Watson and J.H. Wolfe, unpublished
data).
In contrast, following transduction by the EF-nlacZ vector,
transplantation of adult and pup donor cells resulted in estab-
lishment of spermatogenic colonies arising from transduced
GSCs in 28.6% (8/28) and 100% (23/23) of recipient testes,
respectively (Fig. 1 and Table 1). The transduced stem cells
generated complete spermatogenesis following transplanta-
tion, as indicated by the production of spermatozoa in these
colonies (Fig. 1D). Although all recipient testes contained
donor-derived colonies at all time points when pup donor cells
were used (Table 1, line 8), no colonies were observed in
recipient testes analyzed 6 months following transplantation,
when adult donor cells were used (Table 1, line 4). However,
when the data were examined by chi-square analysis, the dif-
ference between adult testis cells at 2^3 months vs. 6 months
was not signi¢cant (P=0.368), suggesting that the absence of
adult donor-derived colonies at 6 months resulted from the
small number of recipient testes analyzed, rather than attenu-
ation of marker gene expression.
To evaluate the regeneration e⁄ciency of donor-derived
spermatogenesis arising from GSCs transduced by the EF-
nlacZ lentivirus, we determined the testis cell transduction
e⁄ciency (TE) for adult and pup donor cells. The TE is cal-
culated from the number of spermatogenic colonies expressing
the marker gene per 106 donor testis cells originally placed in
culture (Table 1), and each colony is considered to arise from
a single stem cell [7,8]. Thus, the value indicates the number of
transduced donor stem cells that colonized recipient testes as a
fraction of all donor testis cells cultured. When adult testis
cells were used, 19 colonies were obtained in 28 recipient
testes, which were transplanted with 6.6U105 cells/testis (Ta-
ble 1, line 4), resulting in a transduction e⁄ciency of 1.0 [(19
colonies)U106/(6.6U105 cells/testisU28 testes)]. Calculated in
the same manner, the value for pup testis cells was 4.6 (Table
1, line 8). Therefore, transduction e⁄ciency was 4.6-fold
greater for pup than adult donor testis cells. This di¡erence
was not due to variation in lentivirus titer among experiments
because no correlation was observed between testis cell TE
and virus titer (Table 1, columns 3 and 8).
These results, which suggest that pup GSCs are more e⁄-
ciently transduced than adult GSCs, are more compelling
when one considers that pup testes contain a lower stem cell
concentration than adult cryptorchid testes [18]. We previ-
ously demonstrated that when donor cells with a reporter
transgene were transplanted without culture, 358 and 140 col-
onies were established per 106 donor cells derived from adult
cryptorchid and pup testes, respectively [8]. Using these values
as denominators, we next calculated the stem cell TE, which
represents the percentage of GSCs that were transduced in
vitro. We found that 0.3% (1.0/358) of adult GSCs and
3.3% (4.6/140) of pup GSCs originally placed in culture
were transduced by lentiviral vectors, indicating that stem
cell TE was 11-fold (3.3/0.3) higher for donor pup than adult
GSCs (Table 2). A similar age-related di¡erence in testis cell
TE and stem cell TE was observed in our previous studies of
GSC transduction by an MMLV-based vector [7,8]. When a
MMLV vector was used, testis cell TE and stem cell TE were
Fig. 1. Spermatogenesis arising from GSCs transduced in vitro by
EF-nlacZ vector following transplantation into recipient testes. Re-
cipient testes were stained for lacZ activity to detect colonies of
spermatogenesis expressing the reporter gene. A: Spermatogenic col-
onies derived from adult donor cells. Three months after transplan-
tation. B: Spermatogenic colonies derived from pup donor cells.
Three months after transplantation. In A and B, blue segments of
seminiferous tubules represent colonies of donor-derived spermato-
genesis arising from transduced GSCs. C: Histology of spermato-
genic colony derived from transduced pup GSCs. Two months fol-
lowing transplantation. Counter-stained with eosin. D: Higher
magni¢cation of C. Note qualitatively complete spermatogenesis
with spermatozoa (arrows). Scale bars: A and B=2 mm, C=100
Wm, D=40 Wm.
Table 2
Comparison of male GSC transduction by lentiviral and MMLV-based vectors
Vector type TEa Adult donor Pup donor Pup/adultb
Lentivirusc Testis cell TEe 1.0 4.6 4.6
Stem cell TEf 0.3 3.3 11
MMLVd Testis cell TEe 0.7 2.5 3.6
Stem cell TEf 0.2 1.8 9
aTransduction e⁄ciency.
bRatio of TE values for pup and adult donor cells.
cMale GSC transduction by a lentiviral vector (this study).
dMale GSC transduction by a MMLV-based vector [7].
eTestis cell TE represents the number of colonies generated from 106 testis cells originally placed in culture.
fStem cell TE represents percentage of GSC transduced in vitro by viral vectors. Stem cell TE for MMLV was calculated in the same manner
as in this study; 0.7/358= 0.2% for adults and 2.5/140= 1.8% for pups.
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approximately 3.6-fold and nine-fold higher for pup than
adult GSCs, respectively (Table 2).
Calculation of transduction e⁄ciency for both stem cell and
testis cell populations from adults and pups allowed identi¢-
cation of factors contributing to successful regeneration of
spermatogenesis from transduced GSCs. First, stem cell TE
values were higher (V10-fold) for pup than adult GSCs re-
gardless of viral vector types (Table 2), suggesting that either
the level of viral receptor expression or the cell cycle activity is
higher in pup than adult GSCs, since these are two important
limiting factors in viral transduction [5,6]. However, it is un-
likely that the di¡erence in expression levels of viral receptors
was a signi¢cant cause, since this lentivirus does not require
speci¢c proteins on the target cell surface for viral entry [11].
Rather, it is more likely that pup GSCs are more active in cell
cycle progression than adult GSCs, which results in a better
transduction e⁄ciency. This would apply particularly to
MMLV retroviral vectors, since the rate of host cell division
is a signi¢cant limiting factor for these viruses [5,6]. Although
the lentivirus is capable of transducing non-dividing cells,
transduction of quiescent cells arrested at the G0 stage in
the cell cycle is less e⁄cient due to a requirement for deoxy-
nucleoside triphosphates that can lead to a block at the re-
verse transcription step [19^23]. Therefore, our results using
lentiviral and MMLV-based vectors suggest that V10-fold
more pup GSCs are actively progressing through the cell cycle
in vitro than adult GSCs. Second, regardless of vector types,
the age-related di¡erence of testis cell TE was less than that of
stem cell TE (V4-fold vs. V10-fold, Table 2), probably be-
cause of the lower concentration of donor stem cells in pup vs.
adult cryptorchid testes [18]. In addition, regeneration e⁄-
ciency of spermatogenesis arising from transduced GSCs is
also in£uenced by recipient environment. By using infertile
pups rather than infertile adults as recipients, regeneration
of spermatogenesis following transplantation can be increased
for both pup and adult donor cells [7,8]. Combined with our
¢nding that pup donor cells are more e⁄ciently transduced,
this shows that the best system for viral vector transduction of
male GSCs and transgenesis is provided by using donor cells
from pups for transduction followed by transplantation into
infertile recipient pup testes.
It has been suggested that self-inactivating lentivirus-based
vectors have several potential advantages relative to ecotropic
MMLV-based vectors [5]. Lentiviral vectors can: (1) be pseu-
dotyped with VSV-G to achieve high titers (s 108 U/ml) and
to allow transduction of a broad range of host cell types and
species; (2) deliver a vector gene that is expressed for long
periods without transgene silencing because negative regula-
tory elements in the long terminal repeat (LTR) are absent;
and (3) transduce both dividing and non-dividing cells. How-
ever, the results of our present and previous studies indicate
that transduction e⁄ciency of male GSCs by a lentiviral- and
MMLV-based vector is similar (Table 2). Several relevant
observations are consistent with our ¢ndings. First, Barrette
et al. [24] demonstrated that a mouse-speci¢c ecotropic
MMLV vector transduced mouse hematopoietic stem cells
(HSCs) as e⁄ciently as a lentiviral vector, indicating that an
envelope protein appropriate for the host cell species allows
e⁄cient transduction of HSCs by MMLV. Likewise, trans-
duction e⁄ciency by ecotropic MMLV and lentivirus was
similar in our studies with mouse GSCs. Both lentiviral and
MMLV vectors pseudotyped with VSV-G can be produced at
high titers, and both vectors when pseudotyped will have a
wide range of host species and cell types [25,26]. Thus, while
our studies were done with mice, they suggest that VSV-G
pseudotyped lentiviral and MMLV vectors could have similar
e⁄ciencies in transducing male GSCs derived from other ani-
mal species. Second, recent observations indicate that vector
gene silencing can be a problem with both lentivirus and
MMLV [5,27]. In the present study, the CMV enhancer/pro-
moter was not e¡ective in achieving lentiviral transduction
and expression in GSCs. In contrast, MMLV [7,8] and lenti-
viral (present study) vectors with other promoters were dem-
onstrated to successfully transduce GSCs without transgene
silencing. Therefore, transgene expression can be a¡ected by
vector construction (e.g. LTR, internal promoter, etc.) for
both MMLV and lentiviral vectors. Third, it has been re-
ported that lentiviral transduction requires host cell cycle pro-
gression to at least the G1b stage in HSCs [23]. Since at least
75% of HSCs are resting at the G0 stage in the cell cycle [28],
this high percentage of quiescent cells may preclude e⁄cient
transduction by lentiviral vectors [22,23]. The majority of
GSCs also is believed to be quiescent [1], which may be the
cause of similar transduction e⁄ciencies for lentiviral and
MMLV vectors in GSCs. Thus, it appears that the advantages
of pseudotyping and the problems of vector construction (e.g.
LTR- and promoter-type) are applicable to both lentiviral and
MMLV vectors, and cell cycle kinetics of the target cell may
be the major factor in determining transduction in these GSC
populations. A similar situation may exist for other stem cells.
The transduction e⁄ciency for GSCs found in the present
study for lentiviral vectors was similar to those found previ-
ously for MMLV vectors using the same experimental condi-
tions. Thus, if appropriate modi¢cations were made to each
vector (e.g. pseudotyping, internal promoter, etc.), both viral
vectors should prove useful in generating transgenic animals
in a wide range of species. In addition to optimizing vector
characteristics, our studies suggest that improvement of male
GSC transduction by either vector will require development of
techniques to activate the cell cycle in GSCs (e.g. culture con-
ditions, growth factors, etc.). Finally, based on our results in
this and previous studies, the use of donor stem cells from
immature animals transplanted to immature recipients will
provide the best system to generate transgenic animals using
spermatogonial stem cell transplantation in mice and possibly
other species.
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